good points Andrew but cash is the issue recognising revenue ahead of cash is not a good outcome this is my last post on this stock good luck
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025